Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat

American Journal of Hypertension

Volumn 10, Issue 4 I, 1997, Pages 371-378

  Sasaki, Masato ^b   Hori, Mark T ^b   Hino, Toru ^b   Golub, Michael S ^b   Tuck, Michael L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

arachidonic acid pathway; calcium; lipoxygenase; spontaneously hypertensive rat

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 5,8,11 ICOSATRIYNOIC ACID; ALDOSTERONE; ANGIOTENSIN; LIPOXYGENASE; POTASSIUM; RENIN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; AGING; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; CALCIUM; CELLS, CULTURED; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0031002609     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00488-8     Document Type: Article

References (43)

1. Gryglewski RJ, Bunting S, Moncada S, et al: Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 1976;12:685-713.
2. Katayama S, Lee JB: Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction. Hypertension 1985;7:554-556.
3. Limas C, Goldman P, Limas CJ, Iwai J: Effect of salt on prostaglandin metabolism in hypertension-prone and resistant Dahl rats. Hypertension 1981;3:219-224.
4. Toda N: Mechanism of action of carbocyclic thromboxane A2 and its interaction with prostaglandin 12 and verapamil in isolated arteries. Circ Res 1982;51:675-682.
5. Ally AI, Horrobin DF: Thromboxane A2 in blood vessel walls and its physiological significance: relevance to thrombosis and hypertension. Prostaglandins Leukotrienes Med 1980;4:431-438.
6. Geoffroy J, Benzoni D, Vincent M, Sassard J: Thromboxane A2 and development of genetic hypertension in the Lyon rat strain. Hypertension 1990;16:655-661.
7. Nozawa K, Tuck ML, Golub MS, et al: Inhibition of the lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol 1990; 259:H1774-H1780.
8. Nozawa K, Tuck ML, Golub M, et al: Hypotensive effects of lipoxygenase inhibition phenidone in two-kidney, one clip Goldblatt hypertension. Am J Hypertens 1989;2:853-855.
9. Saito F, Hori MT, Ideguchi Y, et al: 12-lipoxygenase products modulate calcium signals in vascular smooth muscle cells. Hypertension 1992;20:32-41.
10. Nadler JL, Natarajan R, Stern N: Specific action of the lipoxygenase pathway in mediating angiotensin Il induced aldosterone synthesis in isolated adrenal glomerulosa cells. J Clin Invest 1987;80:1763-1769.
11. Stern N, Nozawa K, Golub M, et al: The lipoxygenase inhibitor phenidone is a potent hypertensive agent in the spontaneously hypertensive rat. Am J Hypertens 1993;6:52-58.
12. Hammarstrom S: Selective inhibition of platelet n-8 lipoxygenase by 5,8,11-eicosatriynoic acid. Biochim Biophys Acta 1977;487;517-519.
13. Blomgren H, Hammarstrom S, Wasserman J: Synergistic enhancement of mitogen response of human lymphocytes by inhibitors of cyclo-oxygenase and 5,8,11-eicosatriynoic acid, an inhibitor of 12-lipoxygenase and leukotriene biosynthesis. Int Arch Allergy Appl Immunol 1987;83:247-255.
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3340-3450.
15. Stern N, Golub M, Nozawa K, et al: Selective inhibition of angiotensin II mediated vasoconstriction by lipoxygenase blockade. Am J Physiol 1989;257:H434-H443.
16. Natarajan R, Stern N, Hsueh W, et al: Role of the lipoxygenase pathway in mediating aldosterone synthesis in normal and adenomatous human glomerulosa cells. J Clin Endocrinol Metab 1988;67:584-591.
17. Natarajan R, Gonzales N, Hornsby PJ, Nadler J: Mechanism of angiotensin II-induced proliferation in bovine adrenocortical cells. Endocrinology 1992;131:1174-1180.
18. 18: Lin L, Balazy M, Pagano PJ, Nasjletti A: Expression of prostaglandin H2-mediated mechanism of vascular contraction in hypertensive rats. Relation to lipoxygenase and prostacyclin synthase activities. Circ Res 1994; 74:197-205.
19. Cachofeiro V, Nasjletti A: Role of prostaglandins in the increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Am J Hypertens 1992;5:193-196.
20. Nyby MD, Berger ME, Wynne HE, et al: Relative influence of cyclooxygenase and lipoxygenase on thrombin-inauced platelet calcium mobilization (abst). Clin Res 1990;38(2):368A.
21. Nyby M, Sasaki M, Ideguchi Y, et al: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane-induced intracellular calcium mobilization and aggregation. J Pharmacol Exper Ther 1996;278.503-509.
22. Gecse A, Sonkondi S, Mezei Z, Telegdy G: Arachidonate cascade in mesenteric blood vessels and platelets of spontaneously hypertensive rats. Agents Actions 1987;22:43-48.
23. Takayama H, Gimbrone MAJ, Schafer Al: Vascular lipoxygenase activity: synthesis of 15-hydroxyeicos-atetranoic acid from arachidonic acid by blood vessels and cultured endothelial cells. Throm Res 1987;45:803-816.
24. Greenwald JE, Bianchine JR, Wong L: The production of the arachidonate metabolite HETE in vascular tissue. Nature 1979;281:588-589.
25. Larrue J, Rigand M, Razaka G, et al: Formation of monohydroxy-eicosatetranoic acids from arachidonic acids by cultured rabbit smooth muscle cells. Biochem Biophys Res Commun 1983;112:242-249.
26. Moore SA, Giordano MJ, Kim H, et al: Brain microvessel 12-hydroxyeicosatetraenoic acid is the (S) enantiomer and is lipoxygenase derived. J Neurochem 1991; 57:922-929.
27. Sato K, Ozaki H, Karaki H: Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator fura 2. J Pharmacol Exp Ther 1988; 246:294-300.
28. Sakata K, Ozaki H, Kwon SC, Karaki H: Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscle. Br J Pharmacol 1989;98:483-492.
29. Nakao J, Ito H, Chang W, et al: Aortic smooth muscle cell migration caused by platelet-derived growth factor is mediated by lipoxygenase product(s) of arachidonic acid. Biochem Biophys Res Commun 1983;112(3):866-871.
30. Setty BNY, Werner MH, Hannun YA, Stuart MJ: 15-Hydroxyeicosatetraenoic acid-mediated potentiation of thiombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers sn-1,2-diacylglycerol and inositol1,4,5-trisphosphate. Blood 1992;80(11):2765-2773.
31. Setty BNY, Graeber JE, Stuart MJ: The mitogenic effect of 15-and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition. J Biol Chem 1987;262(36):17613-17622.
32. Friedlander G, le Grimellec C, Sraer J, Amiel C: 12-HETE modulates Na-coupled uptakes in proximal tubular cells: role of diacylglycerol kinase inhibition. Am J Physiol 1990;259:F816-F822
33. Sekiya F, Takagi J, Usui T, et al: 12-Hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation. Biochem Biophys Res Commun 1991;179:345-351.
34. Clark CJ, Milligan G, McLellan AR, Connell MC: Guanine nucleotide regulatory proteins in the spontaneously hypertensive rat. Hypertension 1993;21:204-209.
35. Hadjiagapiou C, Spector AA: 12-Hydroxyeicosatetraenoic acid reduces prostacyclin production by endothelial cells. Prostaglandins 1986;31:1135-1144.
36. Xuan YT, Watkins WD, Whorton AR: Regulation of endothelin-mediated calcium mobilization in vascular smooth muscle cells by isoproterenol. Am J Physiol 1991;260(3 Pt 1):C492-C502.
37. Yamagishi T, Yanagisawa T, Satoh K, Taira N: Relaxant mechanisms of cyclic AMP-increasing agents in porcine coronary artery. Eur J Pharmacol 1994;251 (2-3):253-262.
38. Schafer AI, Takayama H, Farrell S, Gimbrone MA: Incorporation of platelet and leukocyte lipoxygenase metabolites by cultured vascular cells. Blood 1986; 67(2):373-378.
39. Specter AA, Gordon JA, Moore SA: Hydroxyeicosatetraenoic acids (Review). Prog Lipid Res 1988;27:271-323.
40. Sowers J, Tuck ML, Asp ND, Sollars E: Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats. Endocrinology 1981;108:1216-1221.
41. Antonopilai I, Nadler JL, Robin EC, Horton R: The inhibitory role of 12- and 15-lipoxygenase products on renin release. Hypertension 1987;10:61-66.
42. Antonopillai I, Nadler JL, Horton R: Angiotensin feedback inhibition on renin release is expressed via the lipoxygenase pathway. Endocrinology 1988;122:1277-1281.
43. Ullian ME, Schelling JR, Linas SL. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension 1992;20(1):67-73.